Screening and Access to Health Care for Vascular Disease
1 other identifier
observational
190
1 country
1
Brief Summary
This is a pilot study designed to validate our methods of recruitment, screening and data collection in the community. The project will help to establish the feasibility of the study design to lay the groundwork for a potentially larger study. The final study will allow us to estimate the incidence and prevalence of abdominal aortic aneurysm (AAA), carotid artery stenosis, and peripheral artery disease (PAD) in different geographic areas in a large urban setting, as well as determine patient access to healthcare and treatment for vascular disease as related to geographic and racial differences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2013
CompletedFirst Posted
Study publicly available on registry
June 28, 2013
CompletedStudy Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedSeptember 28, 2023
June 1, 2023
6.9 years
June 26, 2013
September 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Geographic and racial differences in access to follow-up care if significant disease is identified through the screening event
5 years
Secondary Outcomes (3)
Geographical and racial differences in patterns of accessing healthcare prior to the screening events.
1 year
Differences in rates of interventions throughout the 5 year follow-up period.
5 years
Differences in the rates of complications related to treatment of vascular disease in the various geographic areas in which the events are held.
5 years
Eligibility Criteria
Volunteer subjects age 55 and over who sign informed consent will be enrolled in three separate neighborhoods in the Chicago area (North, South, West).
You may qualify if:
- age 55 or older
- willing/able to provide consent
- willing to participate in follow-up phone calls at defined intervals for up to 5 years
You may not qualify if:
- unable to provide consent to participate
- unwilling/unable to participate in the follow-up phone call
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Endeavor Healthlead
- Medtroniccollaborator
Study Sites (1)
NorthShore University HealthSystem
Evanston, Illinois, 60201, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Omar Morcos, MD
Endeavor Health
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2013
First Posted
June 28, 2013
Study Start
June 1, 2014
Primary Completion
May 1, 2021
Study Completion
May 1, 2021
Last Updated
September 28, 2023
Record last verified: 2023-06